scriptcap m7g capping system and scriptcap 2'-o methyltransferase kit (Cellscript Inc)
90
Structured Review
Cellscript Inc
scriptcap m7g capping system and scriptcap 2'-o methyltransferase kit
Scriptcap M7g Capping System And Scriptcap 2' O Methyltransferase Kit, supplied by Cellscript Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scriptcap+m7g+capping+kit+with+2'-o-methyltransferase/m7g+capping+kit+with+2++o+methyltransferase+scriptcap/pm40411488-45-40-43
Average 90 stars, based on 1 article reviews
Scriptcap M7g Capping System And Scriptcap 2' O Methyltransferase Kit, supplied by Cellscript Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/scriptcap+m7g+capping+kit+with+2'-o-methyltransferase/m7g+capping+kit+with+2++o+methyltransferase+scriptcap/pm40411488-45-40-43
Average 90 stars, based on 1 article reviews
scriptcap m7g capping system and scriptcap 2'-o methyltransferase kit - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia. Article Snippet: Pre-eclampsia is a placental disorder that affects 3–5% of all pregnancies and is a leading cause of maternal and fetal morbidity worldwide.. With no drug available to slow disease progression, engineering ionizable lipid nanoparticles (LNPs) for extrahepatic messenger RNA (mRNA) delivery to the placenta is an attractive therapeutic option for pre-eclampsia.. Here we use high-throughput screening to evaluate a library of 98 LNP formulations in vivo and identify a placenta-tropic LNP (LNP 55) that mediates more than 100-fold greater mRNA delivery to the placenta in pregnant mice than a formulation based on the Food and Drug Administrationapproved Onpattro LNP (DLin-MC3-DMA). |